FIELD: medicine. SUBSTANCE: method involves introducing activating solution into the anterior eye segment. The solution has carnosine, glucosamine glycane complex with cations of at least one metal belonging to the group of calcium, magnesium, zinc, aluminum, copper, iron, manganese. EFFECT: reduced endothelium losses in postoperative period; normalized cornea thickness. 7 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ACTIVATING CORNEA ENDOTHELIUM PROLIFERATION BY APPLYING GLECOMEN SOLUTION | 1999 |
|
RU2151580C1 |
| PHARMACEUTICAL COMPOSITION FOR MEDICINAL PUPIL OF EYE MYDRIASIS IN OPHTHALMOLOGY | 1999 |
|
RU2148404C1 |
| PHARMACEUTICAL COMPOSITION "POLYANESTHETIC" FOR PROLONGED ANESTHETIZATION IN OPHTHALMOLOGY | 2001 |
|
RU2183114C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
| PHARMACEUTICAL COMPOSITION FOR ANESTHESIA IN OPHTHALMOLOGY | 1999 |
|
RU2147876C1 |
| PHARMACEUTICAL COMPOSITION FOR ANALGESIA AND DECREASE OF INFLAMMATION IN OPHTHALMOLOGY | 2000 |
|
RU2173990C1 |
| IRRIGATIVE COMPOSITION "GIDROELASTIC" FOR INTRAOCULAR APPLICATION | 2001 |
|
RU2212883C2 |
| METHOD OF RESTORING DAMAGED ENDOTHELIUM OF CORNEA | 1995 |
|
RU2122383C1 |
| METHOD FOR FINISHING EYE IMPLANTS AND CONTACT LENSES | 1998 |
|
RU2142257C1 |
| SUBSTANCE FOR STIMULATION OF HUMAN CORNEA ENDOTHELIUM PROLIFERATION | 1995 |
|
RU2077328C1 |
